Skyward Specialty Insurance Group Earnings Call Transcripts
Fiscal Year 2026
-
First quarter 2026 delivered strong earnings growth, with operating EPS up 39% and ROE at 20%. Over half of the portfolio is cycle-resistant, and fee-based income is a growing driver. Guidance remains unchanged, with disciplined underwriting and innovation supporting future growth.
-
The meeting confirmed quorum and addressed three main proposals: election of two directors, an advisory vote approving executive compensation, and ratification of Ernst & Young as auditors for 2026. All proposals passed with strong shareholder support.
Fiscal Year 2025
-
Fourth quarter and full-year results set new records for adjusted operating and underwriting income, with strong premium growth and improved combined ratio. The Apollo acquisition expands specialty offerings and positions the company as a leader in AV insurance, while guidance for 2026 remains unchanged.
-
Record Q3 with 52% premium growth, 89.2% combined ratio, and 19.7% ROE, led by agriculture and strong A&H, Surety, and Specialty Programs. Apollo acquisition remains on track for early 2026, with continued disciplined underwriting amid rising P&C competition.
-
The acquisition will expand the specialty insurance portfolio, add new technology-driven niches, and enhance fee-based income, with a $555 million purchase price and expected double-digit EPS accretion in the first year post-closing. Integration is planned for Q1 2026, with strong cultural alignment and leadership experience supporting execution.
-
Second quarter results set new records for underwriting income and combined ratio, with 18% premium growth and strong performance in Agriculture, Credit, A&H, and Captives. Conservative reserving, disciplined cycle management, and technology investments underpin continued outperformance.
-
Record Q1 results with net income of $42M and 17% premium growth, led by Agriculture and A&H. Combined ratio improved to 90.5%, and investment income rose. Confident in mid-teens growth for the year, with strong retention and disciplined underwriting amid a softening market.
Fiscal Year 2024
-
Adjusted operating income rose 28% year-over-year, with strong premium growth and a 16.3% ROE. The company is guiding for continued premium growth and stable combined ratios in 2025, focusing on less cycle-exposed segments and maintaining a cautious approach to casualty lines amid loss inflation.
-
Q3 2024 saw strong earnings growth, with net income up 69% year-over-year and a 92.2% combined ratio. Premiums and investment income rose, while the company maintained conservative reserving and announced a $50 million share repurchase. Growth outlook remains robust.
-
Q2 delivered record adjusted operating income and strong premium growth, with underwriting and investment income both sharply higher year-over-year. Focused expansion in less cyclical lines and disciplined risk management drove profitability, while an AM Best upgrade and talent wins further strengthened the outlook.
-
A diversified specialty insurer leverages a people-centric culture, advanced technology, and disciplined underwriting to achieve strong growth in profitable lines, maintain a sub-30% expense ratio, and deliver a sub-90 combined ratio. Focus remains on complex risks, mid-to-large accounts, and ongoing investment in analytics and talent.